跳转至内容
Merck
CN

SML4018

VER-246608

≥98%

别名:

N-[4-(2-Chloro-5-methyl-4-pyrimidinyl)phenyl]-N-[[4-[[(2,2-difluoroacetyl)amino]methyl]phenyl]methyl]-2,4-dihydroxybenzamide, N-[4-(2-Chloro-5-methylpyrimidin-4-yl)phenyl]-N-([4-[(2,2-difluoroacetamido)methyl]phenyl]methyl)-2,4-dihydroxybenzamide, VER 246608

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C28H23ClF2N4O4
化学文摘社编号:
分子量:
552.96
MDL number:
NACRES:
NA.21
Assay:
≥98%
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear (Warmed)

SMILES string

O=C(N(CC1=CC=C(CNC(C(F)F)=O)C=C1)C2=CC=C(C3=NC(Cl)=NC=C3C)C=C2)C4=CC=C(C=C4O)O

assay

≥98%

storage temp.

-10 to -25°C

Quality Level

Biochem/physiol Actions

An ATP-competitive, potent pan-PDK inhibitor that efficiently disrupts Warburg metabolism
VER-246608 is a cell-permeable resorcinol amide compound that acts as a potent, selective, reversible, and ATP-competitive inhibitor of pan-PDK isoform PDK (IC50 = 35, 84, 40 and 91 nM against PDK1, PDK2, PDK3 and PDK4, respectively) with minimal activity towards HSP-90 (IC50 > 10 µM). VER-246608 effectively enhances PDHA1 (pyruvate dehydrogenase E1-alpha subunit) activity and markedly diminishes PDHA1-Ser293 and -Ser300 phosphorylations without inducing severe cancer cell death. Efficiently disrupts Warburg metabolism and demonstrates cancer cells growth arrest under nutrient-deficient conditions. Also inhibits tumor spheroids growth with a potency that was comparable to cells grown in 2D-culture.

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持